Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets... Show more
TECH is expected to report earnings to rise 21.81% to 51 cents per share on April 30
Q1'25
Est.
$0.51
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.01
Q1'24
Beat
by $0.03
The last earnings report on February 05 showed earnings per share of 41 cents, beating the estimate of 38 cents. With 1.99M shares outstanding, the current market capitalization sits at 8.67B.